Rebecca Archer, a mother in Salford, England, lost her daughter Renae to a rare measles complication in 2023. Renae contracted the virus as an infant during a 2013 outbreak that produced over 1,000 suspected cases, a surge linked to plummeting MMR uptake after the discredited Andrew Wakefield study. The vaccine is given at age one, leaving babies vulnerable and highlighted a public‑health failure.

At age ten, Renae began missing school activities, her handwriting wavered, and she suffered a series of seizures. MRI scans revealed progressive brain swelling, eventually identified as subacute sclerosing panencephalitis, the fatal sequel of measles infection. Despite intensive care, antibiotics and plasma exchange, she slipped into a coma and died nine days before her 11th birthday.

Britain’s measles‑elimination status was revoked in January 2024, with national MMR coverage stalled at 84%, well under the WHO’s 95% target. In the United States, overall coverage sits at 92% but varies widely because many states permit personal‑belief exemptions, fueling the highest case count in three decades. Archer’s tragedy underscores how individual vaccine choices can undermine herd immunity and revive a virus once thought controlled.